EP 1718618 A1 20061108 - PYRAZOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER
Title (en)
PYRAZOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER
Title (de)
ZUR BEHANDLUNG VON KREBS GEEIGNETE PYRAZOLINDERIVATE
Title (fr)
DERIVES DE PYRAZOLINE UTILES DANS LE TRAITEMENT DU CANCER
Publication
Application
Priority
- EP 2005001656 W 20050216
- ES 200400362 A 20040216
- US 80469504 A 20040319
Abstract (en)
[origin: WO2005077910A1] The present invention relates to new substituted pyrazoline compounds, pharmaceutical compositions containing such compounds and the use of these compounds for the treatment of cancer, in particular for the treatment of brain cancer, bone cancer, lip cancer, mouth cancer, esophageal cancer, stomach cancer, liver cancer, bladder cancer, pancreas cancer, ovary cancer, cervical cancer, lung cancer, breast cancer, skin cancer, especially for the treatment of colon cancer and/or bowel cancer and/or prostata cancer.
IPC 8 full level
C07D 231/06 (2006.01); A61K 31/415 (2006.01); A61K 31/4152 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR)
A61K 31/415 (2013.01 - KR); A61P 35/00 (2017.12 - EP); C07D 231/06 (2013.01 - EP KR)
Citation (search report)
See references of WO 2005077910A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
LV
DOCDB simple family (publication)
WO 2005077910 A1 20050825; AU 2005212833 A1 20050825; BR PI0507718 A 20070703; CA 2556478 A1 20050825; EP 1718618 A1 20061108; JP 2007522180 A 20070809; KR 20070044799 A 20070430; NO 20064185 L 20061113; RU 2006133150 A 20080410
DOCDB simple family (application)
EP 2005001656 W 20050216; AU 2005212833 A 20050216; BR PI0507718 A 20050216; CA 2556478 A 20050216; EP 05707483 A 20050216; JP 2006552580 A 20050216; KR 20067018161 A 20060906; NO 20064185 A 20060915; RU 2006133150 A 20050216